acetylglucosamine has been researched along with Cholangiocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Phoomak, C; Puapairoj, A; Silsirivanit, A; Sripa, B; Wongkham, C; Wongkham, S | 1 |
| Phoomak, C; Saengboonmee, C; Sawanyawisuth, K; Seubwai, W; Silsirivanit, A; Vaeteewoottacharn, K; Wongkham, C; Wongkham, S | 1 |
2 other study(ies) available for acetylglucosamine and Cholangiocellular Carcinoma
| Article | Year |
|---|---|
Overexpression of O-GlcNAc-transferase associates with aggressiveness of mass-forming cholangiocarcinoma.
Topics: Acetylglucosamine; Cholangiocarcinoma; Down-Regulation; Glycosylation; Humans; Protein Processing, Post-Translational; Up-Regulation | 2012 |
High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation.
Topics: Acetylglucosamine; Acylation; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Cholangiocarcinoma; Dose-Response Relationship, Drug; Glucose; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Humans; N-Acetylglucosaminyltransferases; Neoplasm Metastasis; Nitrogenous Group Transferases; Vimentin | 2017 |